Floatz logo

PANTOPRAZOLE

Prevention & Control

BayerSmall moleculePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Prevention & Control cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Bayer
Phase 3BB
BAY 59-7939
Bayer
Phase 3BB
Rivaroxaban
Bayer
Phase 3BB
Epigallocatechin-3-Gallate
Shandong Cancer Hospital and Institute
Phase 2CCC

Same molecule, other indications

PANTOPRAZOLE is also rated in:

gastroesophageal reflux diseaseDormant
BB
Indicative ·
68 / 100
View asset →
Acute PsychosisDormant
BB
Indicative ·
66 / 100
View asset →
Migraine, HemicraniaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →